eClinical Tech News

uniQure reported full-year 2025 results and a pivotal regulatory update: after a Type A meeting in January, FDA advised...

Denali Therapeutics has finalized U.S. launch readiness for tividenofusp alfa (DNL310) in Hunter syndrome ahead of an April 5,...

Biodesix reported a breakout quarter to close 2025, delivering $28.8 million in Q4 revenue with 83% gross margins and,...

mdxhealth posted fourth-quarter revenue of $29.5 million, up 19% year over year, and full-year 2025 revenue of $107.9 million,...

Ligand Pharmaceuticals reported a decisive acceleration in its royalty-driven model, with full-year 2025 royalty revenue up 48% to $161...

Rhythm Pharmaceuticals reported fourth-quarter 2025 net product revenue of $57.3 million and set a near-term regulatory catalyst: a March...

Indivior posted record quarterly and full-year performance anchored by Sublocade, its long-acting buprenorphine injection for opioid use disorder. Total...

Kymera Therapeutics closed 2025 with two Phase 2b trials underway for KT-621, its first-in-class oral STAT6 degrader, in atopic...

argenx reported a breakout 2025: $4.2 billion in global product net sales for the year, up 90% year over...

Recursion reported fourth quarter and full-year 2025 results with a pivotal operational milestone: the company delivered its first AI-enabled...